Only about 6% of the more than 750 American hospitals that perform transcatheter aortic valve replacement, a minimally invasive heart valve replacement procedure, have earned this designation.
The certification is a designation of excellence that recognizes demonstrated expertise and commitment in treating patients undergoing transcatheter valve repair and replacement procedures, including TAVR.
ACC awards this certification following a rigorous, months-long evaluation of the team’s ability to meet standards for multidisciplinary teams, formalized training, shared decision-making and registry performance.
Dr. John Brown III, the Grant V. Parr Chair, Division of Cardiovascular Surgery, and vice chair, cardiovascular medicine, at Morristown Medical Center, was thrilled by the recognition.
“The ACC Transcatheter Valve Certification provides external confirmation of what our team of professionals and patients already know: We have one of the best TAVR programs and teams in the nation, with outstanding outcomes and a dedication to continuously improving the quality of our program,” he said. “This elite certification also validates our commitment to provide the highest quality multidisciplinary, evidence-based care in advancing the field of structural heart disease research.”
Morristown Medical Center, the top-ranked hospital in New Jersey, is one of the Top 40 programs in the country for cardiology and cardiac surgery (according to U.S. News & World Report) and one of America’s 100 Best Hospitals for cardiac care (according to Healthgrades).
Dr. Philippe Genereux, co-director of the structural heart program at Morristown Medical Center, said the latest honor is significant.
“The American College of Cardiology is one of the world’s most widely respected standard-setting organizations for cardiologists and heart hospitals, and has extremely strict standards for certification,” he said. “This recognition demonstrates how the Morristown Medical Center Valve and Structural Heart Center incorporates best practices, as determined by recent guidelines and expert consensus statements, into the care of our transcatheter valve patients.
“As the region’s leader in cardiac care, we are committed to translating these practices into the highest quality treatments for our patients, with the best outcomes.”